What is Scotiabank’s Estimate for Albemarle FY2026 Earnings?

Albemarle Corporation (NYSE:ALB) – Equities research analysts at Scotiabank cut their FY2026 earnings per share (EPS) estimates for Albemarle in a report released on Monday, November 9th. Scotiabank analyst B. Isaacson now forecasts that the specialty chemicals company will post earnings of $10.36 per share for the year, down from their prior forecast of $11.64. Scotiabank has a “Sector Outperform” rating and a $165.00 price objective on the stock. The consensus estimate for Albemarle’s current full-year earnings is $10.84 per share. Scotiabank also issued estimates for Albemarle’s FY2027 earnings at $9.98 EPS.

Albemarle (NYSE:ALB) last released its quarterly earnings data on Wednesday, November 4th. The specialty chemicals company reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.05. Albemarle had a return on equity of 14.91% and a net margin of 10.40%. The firm had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.52 billion. During the same quarter in the prior year, the company earned ($0.19) earnings per share. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year.

A number of other equities research analysts have also recently weighed in on ALB. Argus dropped their price target on Albemarle from $230.00 to $135.00 and set a “buy” rating on the stock in a research note on Wednesday, October 7th. Royal Bank Of Canada cut their price target on Albemarle from $129.00 to $119.00 and set an “outperform” rating for the company in a report on Friday, November 6th. UBS Group reduced their price objective on shares of Albemarle from $150.00 to $137.00 and set a “buy” rating for the company in a research report on Monday. Truist Financial reiterated a “buy” rating and issued a $170.00 price objective (down from $185.00) on shares of Albemarle in a report on Friday, November 6th. Finally, Wall Street Zen lowered shares of Albemarle from a “buy” rating to a “hold” rating in a research report on Saturday. Fifteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $174.05.

Albemarle Stock Performance

Shares of NYSE ALB opened at $94.98 on Wednesday. The company has a current ratio of 2.34, a quick ratio of 1.57 and a debt-to-equity ratio of 0.21. Albemarle has a 12 month low of $89.77 and a 12 month high of $221.00. The stock has a 50 day moving average of $106.02 and a 200-day moving average of $147.00. The company has a market capitalization of $11.21 billion, a P/E ratio of 22.94, a P/E/G ratio of 0.61 and a beta of 1.34.

Hedge Funds Weigh In On Albemarle

Several institutional investors and hedge funds have recently made changes to their positions in ALB. GW&K Investment Management LLC boosted its position in shares of Albemarle by 12,206.4% in the third quarter. GW&K Investment Management LLC now owns 32,612 shares of the specialty chemicals company’s stock valued at $3,450,000 after acquiring an additional 32,347 shares during the period. Private Advisor Group LLC grew its stake in shares of Albemarle by 529.2% in the third quarter. Private Advisor Group LLC now owns 27,032 shares of the specialty chemicals company’s stock valued at $2,859,000 after acquiring an additional 22,736 shares in the last quarter. Focus Advisor Solutions LLC grew its stake in shares of Albemarle by 49.9% in the third quarter. Focus Advisor Solutions LLC now owns 5,675 shares of the specialty chemicals company’s stock valued at $600,000 after acquiring an additional 1,890 shares in the last quarter. Aegis Wealth Management LLC increased its position in Albemarle by 34.8% during the third quarter. Aegis Wealth Management LLC now owns 5,391 shares of the specialty chemicals company’s stock worth $570,000 after acquiring an additional 1,391 shares during the period. Finally, Bornite Capital Management LP bought a new position in Albemarle during the third quarter worth about $15,867,000. Institutional investors and hedge funds own 92.87% of the company’s stock.

Albemarle Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Friday, December 18th will be issued a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Friday, December 18th. Albemarle’s payout ratio is currently 39.61%.

About Albemarle

Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.